Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:00 AM EDTCompany ParticipantsMark Kaye - Executive VP ...

Changes to a key component of the Patient Driven Payment Model remain in limbo two years after they were first proposed, but federal regulators are still poised to refine the system to accommodate for ...

Seeing blood in urine is often the first clue that something is wrong. For many people, noticing this symptom prompts a medical visit that can lead ...

The Master of Information Management and Systems (MIMS) program educates information professionals to provide leadership for an information-driven world. The Master of Information and Data Science ...

NIH-funded research suggests AI-powered tool could streamline diagnoses and unveil early markers for chronic disease. March 8, 2026 – National Institutes of Health (NIH) released the following: A ...

Abstract: Millions of people worldwide suffer from Parkinson's disease (PD), a chronic brain ailment. It happens when dopamine, a neurotransmitter that regulates movement, is produced by dying or ...

A research team funded by the National Institutes of Health (NIH) has developed a versatile machine learning model that could one day greatly expand what medical scans can tell us about disease.

A research team funded by the National Institutes of Health (NIH) has developed a versatile machine learning model that could one day greatly expand what medical scans can tell us about disease.

A research team funded by the National Institutes of Health (NIH) has developed a versatile machine learning model that could one day greatly expand ...

As electric scooters and bicycles zip through Oregon neighborhoods and city streets in growing numbers, serious injuries tied ...

The U.S. Centers for Medicare and Medicaid Services alleges the Indianapolis-based health insurer has failed to properly submit required information to federal regulators since 2018.

Federal regulators are planning to suspend enrollment in Elevance's MA plans at the end of March, in a rare and serious threat to the company’s finances.